APR 24, 2018 09:11 PM PDT

New Treatment Option for the Non-Cancerous Form of the Prostate

WRITTEN BY: Nouran Amin

A new therapy known as ‘prostate artery embolization’ or PAE seeks to treat the non-cancerous enlargement of the prostate, or benign prostatic hyperplasia (BPH), which is a common condition seen in older men.

Prostate artery embolization blocks some of the blood supply from reaching the prostate using tiny synthetic beads, ultimately treating troubling tissue. The treatment is non-invasive and may spare men surgery and side-effects including impotence. “Prostate artery embolization gives men with BPH a treatment option that is less invasive than other therapies and allows them to return to their normal lives sooner.”

Having an enlarged prostate is seen in about a third of men over the age of 50, which can make it difficult for them to pass urine. Currently, some drug treatments and surgical interventions can help however, other treatment options should be offered. In fact, roughly 20 research centers in the UK have already placed patients on this treatment has part of a clinical trial.

A consultant interventional radiologist at the University Hospital Southampton, Dr Nigel Hacking, explains that, "It is a particularly good option for men who are not yet ready to undergo more invasive prostate surgery. Maintaining sexual function and fertility is one of its main strengths” says lead author of the PAE study, Joao Martins Pisco, “this minimally invasive treatment is successful in the long term and should always be presented to patients who are exploring options to resolve their BPH.”

The prostate gland is a crucial part of the male reproductive system, and it works to produce the fluid to carry and nurture sperm. With BAE, if left untreated, it may interfere with the bladder function, causing affected men to go use the toilet to pass urine. If BPH is not treated at all it can cause urine infections and/or damage to the bladder and kidneys.

Sources: BBC News, Urology Health

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 14, 2018
Drug Discovery
MAY 14, 2018
Gilenya: First Treatment for Pediatric MS
   A drug known as Gilenya (fingolimod), which was first approved in 2010 for the treatment of Multiple Sclerosis (MS) in adult patients, was rec...
JUL 06, 2018
Cell & Molecular Biology
JUL 06, 2018
Small Molecules Found to Dial Down Autoimmunity
Scientists have now identified two combinations of small molecules that tamp down a protein called STING....
JUL 17, 2018
Drug Discovery
JUL 17, 2018
First Drug for Smallpox Treatment
TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox, was just approved by the U.S. Food and Drug Administration to SIGA Techno...
JUL 31, 2018
Drug Discovery
JUL 31, 2018
DNA For Drug Development?
Genetic data of individuals who were customers of DNA testing service for the purpose of understanding their ancestry and genetic history, such as the comp...
AUG 20, 2018
Drug Discovery
AUG 20, 2018
Drug Seeks To Prevent a Painful Side-Effect
Many patients with head, neck, nasal, and oral cancers are treated with radiations. Unfortunately, such treatment leaves patients with a painful side-effec...
SEP 20, 2018
Drug Discovery
SEP 20, 2018
Chemotherapeutic Drugs Battle Antimalarial Drug Resistance
According to the latest research published in the journal Nature Communications, researchers discovered that chemotherapeutic drugs can increase the effect...
Loading Comments...